TC BIOPHARM HOLDINGS PLC's ticker is and the CUSIP is 87807D111. A total of 6 filers reported holding TC BIOPHARM HOLDINGS PLC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kepos Capital LP | 470,588 | $20 | 0.00% |
| Altium Capital Management LP | 18,823 | $809 | 0.00% |
| Nantahala Capital Management | 235,294 | $10,118 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| ARMISTICE CAPITAL, LLC | 37,647 | $1,619 | 0.00% |
| UBS Group AG | 4,185 | $180 | 0.00% |
This page lists TC BIOPHARM HOLDINGS PLC's shareholders in Q2 2023. To view TC BIOPHARM HOLDINGS PLC's shareholder history, click here.